Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48‐month longitudinal cohort studyKB Sims, Daniel I. Rosenthal, Ramnik J. Xavier et al.|Clinical Genetics|2008Cited by 134
Imiglucerase (Cerezyme<sup>®</sup>) improves quality of life in patients with skeletal manifestations of Gaucher diseaseNeal J. Weinreb, GM Pastores, Katherine B. Sims et al.|Clinical Genetics|2007Cited by 104